|
1
|
McBride MW, Charchar FJ, Graham D, Miller
WH, Strahorn P, Carr FJ and Dominiczak AF: Functional genomics in
rodent models of hypertension. J Physiol. 554:56–63. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Delles C, McBride MW, Graham D,
Padmanabhan S and Dominiczak AF: Genetics of hypertension: from
experimental animals to humans. Biochim Biophys Acta.
1802:1299–1308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Okamoto K and Aoki K: Development of a
strain of spontaneously hypertensive rats. Jpn Circ J. 27:282–293.
1963. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Okamoto K, Hazama F, Yamori Y, Haebara H
and Nagaoka A: Pathogenesis and prevention of stroke in
spontaneously hypertensive rats. Clin Sci Mol Med (Suppl).
2:161s–163s. 1975.PubMed/NCBI
|
|
5
|
Nabika T, Cui Z and Masuda J: The
stroke-prone spontaneously hypertensive rat: how good is it as a
model for cerebrovascular diseases? Cell Mol Neurobiol. 24:639–646.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Friese RS, Mahboubi P, Mahapatra NR, et
al: Common genetic mechanisms of blood pressure elevation in two
independent rodent models of human essential hypertension. Am J
Hypertens. 18:633–652. 2005. View Article : Google Scholar
|
|
7
|
Ashenagar MS, Tabuchi M, Kinoshita K, et
al: Gene expression in the adrenal glands of three spontaneously
hypertensive rat substrains. Mol Med Rep. 3:213–222.
2010.PubMed/NCBI
|
|
8
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
9
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009.PubMed/NCBI
|
|
10
|
Sagvolden T, Russell VA, Aase H, Johansen
EB and Farshbaf M: Rodent models of attention-deficit/hyperactivity
disorder. Biol Psychiatry. 57:1239–1247. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Faraone SV and Mick E: Molecular genetics
of attention deficit hyperactivity disorder. Psychiatr Clin North
Am. 33:159–180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kempf T, Eden M, Strelau J, et al: The
transforming growth factor-beta superfamily member
growth-differentiation factor-15 protects the heart from
ischemia/reperfusion injury. Circ Res. 98:351–360. 2006. View Article : Google Scholar
|
|
13
|
de Jager SC, Bermúdez B, Bot I, et al:
Growth differentiation factor 15 deficiency protects against
atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis.
J Exp Med. 208:217–225. 2011.PubMed/NCBI
|
|
14
|
Liu L and Gudas LJ: Disruption of the
lecithin:retinol acyltransferase gene makes mice more susceptible
to vitamin A deficiency. J Biol Chem. 280:40226–40234. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiu G and Hill JS: Atorvastatin decreases
lipoprotein lipase and endothelial lipase expression in human THP-1
macrophages. J Lipid Res. 48:2112–2122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
García-Cazarín ML, Smith JL, Clair DK and
Piascik MT: The alpha1D-adrenergic receptor induces vascular smooth
muscle apoptosis via a p53-dependent mechanism. Mol Pharmacol.
74:1000–1007. 2008.PubMed/NCBI
|
|
17
|
Denhardt DT and Guo X: Osteopontin: a
protein with diverse functions. FASEB J. 7:1475–1482.
1993.PubMed/NCBI
|
|
18
|
Wang KX and Denhardt DT: Osteopontin: role
in immune regulation and stress responses. Cytokine Growth Factor
Rev. 19:333–345. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reghunandanan V and Reghunandanan R:
Neurotransmitters of the suprachiasmatic nuclei. J Circadian
Rhythms. 4:22006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roubert C, Spielewoy C, Soubrié P, Hamon
M, Giros B and Betancur C: Altered neurotensin mRNA expression in
mice lacking the dopamine transporter. Neuroscience. 123:537–546.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsuo K, Owens JM, Tonko M, Elliott C,
Chambers TJ and Wagner EF: Fosl1 is a transcriptional target of
c-Fos during osteoclast differentiation. Nat Genet. 24:184–187.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hirata H, Tomita K, Bessho Y and Kageyama
R: Hes1 and Hes3 regulate maintenance of the isthmic organizer and
development of the mid/hindbrain. EMBO J. 20:4454–4466. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Senbonmatsu T, Saito T, Landon EJ, et al:
A novel angiotensin II type 2 receptor signaling pathway: possible
role in cardiac hypertrophy. EMBO J. 22:6471–6482. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Scotti E, Hong C, Yoshinaga Y, et al:
Targeted disruption of the idol gene alters cellular regulation of
the low-density lipoprotein receptor by sterols and liver x
receptor agonists. Mol Cell Biol. 31:1885–1893. 2011. View Article : Google Scholar
|
|
25
|
Hartvigsen K, Chou MY, Hansen LF, Shaw PX,
Tsimikas S, Binder CJ and Witztum JL: The role of innate immunity
in atherogenesis. J Lipid Res. 50(Suppl): S388–S393. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Azuma K, Tamura K, Shigenaga A, et al:
Novel regulatory effect of angiotensin II type 1
receptor-interacting molecule on vascular smooth muscle cells.
Hypertension. 50:926–932. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zitvogel L, Kepp O and Kroemer G: Decoding
cell death signals in inflammation and immunity. Cell. 140:798–804.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ueno KI, Togashi H, Mori K, et al:
Behavioural and pharmacological relevance of stroke-prone
spontaneously hypertensive rats as an animal model of a
developmental disorder. Behav Pharmacol. 13:1–13. 2002. View Article : Google Scholar
|
|
29
|
Anderson GM, Dover MA, Yang BP, et al:
Adrenomedullary function during cognitive testing in
attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc
Psychiatry. 39:635–643. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mack JT, Beljanski V, Soulika AM, Townsend
DM, Brown CB, Davis W and Tew KD: ‘Skittish’ Abca2 knockout
mice display tremor, hyperactivity, and abnormal myelin
ultrastructure in the central nervous system. Mol Cell Biol.
27:44–53. 2007.
|
|
31
|
Maldonado R, Smadja C, Mazzucchelli C and
Sassone-Corsi P: Altered emotional and locomotor responses in mice
deficient in the transcription factor CREM. Proc Natl Acad Sci USA.
96:14094–14099. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lahti TA and Partonen T: CREM mutations
and ADHD symptoms. Med Hypotheses. 72:544–545. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Viggiano D, Ruocco LA, Arcieri S and
Sadile AG: Involvement of norepinephrine in the control of activity
and attentive processes in animal models of attention deficit
hyperactivity disorder. Neural Plast. 11:133–149. 2004. View Article : Google Scholar
|
